Hepatitis is an inflammatory disease of the liver and is considered one of the leading causes of death worldwide. Due to its scavenging activity, may be used for the treatment and prevention of liver diseases. The current study investigated the protective mechanism underlying the effects of pomegranate against a rat model of carbon tetrachloride-induced liver injury.
View Article and Find Full Text PDFLiver diseases such as hepatic carcinoma are one of the main health problems worldwide. Herbal drugs are largely used to treat liver injury in the indigenous system of medicine and may provide lead compounds for hepatoprotective drug discovery. The present study is investigated to test the Wall.
View Article and Find Full Text PDFThe demand for natural medicines has increased because of their limited adverse effects. The aim of study is to explore the antidiabetic potential of isolated steroidal alkaloid from Sarcococca saligna in streptozotocin induced diabetic rats. To determine the antidiabetic activity of steroidal alkaloids, diabetes was induced in rats by injecting streptozotocin intraperitoneally at a dose of 40 mg/Kg.
View Article and Find Full Text PDFPhotodiagnosis Photodyn Ther
September 2017
Hepatitis is one of the most common life threatening diseases. The diagnosis is mainly based on biochemical analysis such as liver function test. However, histopathological evaluation of liver serves far better for more accurate final diagnosis.
View Article and Find Full Text PDFThe compounds, sarcovagine-D, alkaloid-C, and holaphylline isolated from were found to possess immunosuppressive activities. These compounds were characterized for inhibition on human T-cells proliferation and IL-2 production. The compounds showed significant immunosuppressive effect on IL-2 production as well as on phytohemagglutinin stimulated T-cell proliferation in a dose dependent manner.
View Article and Find Full Text PDFThis study investigated the molecular mechanism(s) of the protective effects of a -alkylated flavonoid, viscosine on an animal model of CCl-induced hepatotoxicity. Viscosine at 20, 50 and 100 mg kg was orally administered in a dose dependent manner per day for 3 days before the CCl (1 : 1 v/v in olive oil, 1 ml kg) treatment and 2 days after the treatment. Hepatoprotection was assessed in terms of reduction in serum enzyme activities (ALT, AST, and ALP) that occur after CCl injury, and by histopathology and immunohistochemistry.
View Article and Find Full Text PDF